Calidi Biotherapeutics, Inc. (CLDI) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -4.12M | -5.04M | -4.24M | -4.88M | -7.13M | -5.42M | -4.95M | -3.83M | -3.83M | -5.19M | -13.52M | -5.17M | -3.11M | -3.88M | -8.6M | -2.96M | -2.11M | -2.75M | -1.47M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -4680% | -677.78% | - |
| Operating CF Growth % | 42.28% | 6.99% | 14.31% | -27.38% | -86.14% | -4.57% | 63.41% | 25.94% | -23.3% | -33.8% | -57.1% | -74.94% | -47.53% | -41.2% | -485.51% | - | - | - | - |
| Net Income | -4.11M | -4.06M | -5.15M | -5.76M | -5.06M | -4.15M | -5.07M | -5.77M | -7.22M | -8.23M | -2.02M | -12.5M | -6.46M | -7.76M | -5.36M | -4.58M | -7.74M | -3.49M | -823.29K |
| Depreciation & Amortization | 426K | 423K | 427K | 407K | 394K | 393K | 390K | 378K | 374K | 364K | 345K | 364K | 183K | 89K | 200K | 51K | 52K | 45K | 0 |
| Stock-Based Compensation | 231K | 450K | 529K | 522K | 607K | 626K | 692K | 751K | 888K | 1.19M | 1.11M | 1.08M | 1.43M | 1.06M | 1.06M | 936K | 1.47M | 412K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -48K | 117K | 597K | 19K | -35K | -44K | -371K | -1.11M | 215K | -1.5M | -4.64M | 6.82M | 1.73M | 4.1M | -7.17M | 3.15M | 603K | 686K | 718.08K |
| Working Capital Changes | -617K | -1.53M | -113K | -67K | -3.04M | -2.25M | -588K | 1.92M | 1.92M | 2.99M | -8.3M | -938K | 10K | -309K | 3.72M | -2.52M | 3.51M | -399K | -1.36M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 232K | -404K | -191K | 19K | -752K | -1.17M | -605K | 968K | 968K | 1.49M | -5.98M | -1.69M | 21K | 62K | 0 | 0 | 0 | -943K | 0 |
| Cash from Investing | -5K | -79K | -27K | -57K | -7K | -5K | -6K | -5K | -5K | -35K | -63K | -243K | -137K | -161K | -333K | -101K | -99K | -27K | -230M |
| Capital Expenditures | -5K | -29K | -27K | -57K | -7K | -5K | -6K | -5K | -5K | -70K | -72K | -306K | -137K | -161K | -267K | -101K | -99K | -26K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 220% | 6.42% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35K | 9K | 63K | 0 | -190.01M | -66K | 0 | 0 | -1K | -230M |
| Cash from Financing | 5.16M | 340K | 9.48M | -469K | 8.11M | 13.11M | 6.05M | 3.01M | 3.01M | -2.96M | 21.64M | 6.58M | 3.79M | 4.32M | 7.77M | 2.78M | 732K | 1.49M | 232.57M |
| Debt Issued (Net) | -44K | -121K | -719K | -392K | -1.67M | -19K | 582K | 3.18M | 3.18M | -2.3M | -17K | 883K | 3.63M | 1.48M | -96K | -43K | -7K | -33K | -188.8K |
| Equity Issued (Net) | 5.37M | 488K | 10.23M | 3K | 10.08M | 11.66M | 1M | 7.65M | 0 | 0 | 22.11M | 50K | 181K | 2.9M | 7.86M | 0 | 0 | -2.34M | 235.1M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -171K | -27K | -29K | -80K | -301K | 1.47M | 4.46M | -7.81M | -164K | -660K | -457K | 5.69M | -19K | -58K | 4.26M | 2.82M | 739K | 1.52M | -2.34M |
| Net Change in Cash | 1.03M | -4.78M | 5.1M | -5.4M | 970K | 7.69M | 1.06M | -806K | -806K | -8.2M | 8.08M | 1.15M | -389.17K | 432.06K | -288.9K | -288K | -1.48M | -1.28M | 1.1M |
| Free Cash Flow | -4.12M | -5.07M | -4.26M | -4.94M | -7.14M | -5.43M | -4.95M | -3.84M | -3.84M | -5.26M | -13.59M | -5.48M | -3.24M | -4.04M | -8.87M | -3.06M | -2.21M | -2.77M | -1.47M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -4900% | -684.2% | - |
| FCF Growth % | 42.27% | 6.54% | 13.87% | -28.7% | -86.08% | -3.27% | 63.56% | 29.99% | -18.25% | -30.2% | -53.18% | -79.17% | -47.12% | -45.69% | -503.68% | - | - | - | - |
| FCF per Share | -0.40 | -0.70 | -0.87 | -1.72 | -3.18 | -8.17 | -7.63 | -8.67 | -13.00 | -17.83 | -114.41 | -66.83 | -39.57 | -49.24 | -40.34 | -12.82 | -9.24 | -11.61 | -6.16 |
| FCF Conversion (FCF/Net Income) | 1.00x | 1.24x | 0.82x | 0.85x | 1.43x | 1.32x | 0.98x | 0.66x | 0.53x | 0.63x | 6.68x | 0.41x | 0.48x | 0.50x | 1.61x | 0.65x | 0.27x | 0.79x | 1.78x |
| Interest Paid | 101K | 0 | 0 | 198K | 639K | 16K | 8K | 92K | 24K | 370K | 11K | 11K | 0 | 0 | 0 | 8K | 10K | 12K | 0 |
| Taxes Paid | 4K | 0 | 0 | 4K | 3K | 4K | 4K | 4K | 2K | 0 | 3K | 3K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |